Form 4: Corcept Director Gifts Shares in Estate Planning
Insider Transaction Report
Corcept Therapeutics Director James N. Wilson reported gifting 4,000 shares of common stock as part of a routine transaction.
Summary
- Director James N. Wilson of Corcept Therapeutics Inc. reported a change in beneficial ownership.
- On March 20, 2026, Wilson disposed of 4,000 shares of common stock via a gift transaction.
- The transaction price per share was $0.00.
- Following this transaction, Wilson's indirect beneficial ownership includes 1,102,532 shares through the James N. Wilson and Pamela D. Wilson Trust, 901,067 shares through James and Pamela Wilson Family Partners, 200,000 shares through the James N. Wilson 2025 Grantor Retained Annuity Trust, and 200,000 shares through the Pamela D. Wilson 2025 Grantor Retained Annuity Trust.
- Wilson disclaims beneficial ownership of shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners, except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as a gift transaction by an insider is typically for estate planning purposes and does not reflect a change in the company's operational performance or outlook.
Positives
- The transaction was a gift, not a sale for cash, indicating no immediate intent to liquidate for personal gain.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider gift transactions, while not directly impacting company operations, are a common estate planning tool and do not typically signal a change in the insider's view of the company's prospects.
Related Party Transactions
- James N. Wilson gifted shares to various trusts, including the James N. Wilson and Pamela D. Wilson Trust, James and Pamela Wilson Family Partners, James N. Wilson 2025 Grantor Retained Annuity Trust, and Pamela D. Wilson 2025 Grantor Retained Annuity Trust.
Stakeholder Impact
- Shareholders: Minimal direct impact; a slight reduction in the director's direct holdings, but shares remain within related entities.
Key Dates
| Date | Description |
|---|---|
| 03/20/2026 | Date of transaction where 4,000 shares of common stock were disposed of by gift. |
| 03/24/2026 | Date the Form 4 was signed by Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson. |
Recommendation
holdThe filing reports a routine insider gift transaction, which is typically for estate planning and does not reflect on the company's operational performance or future prospects. As such, it does not provide a basis for a change in investment recommendation.
Keywords
Corcept Therapeutics, CORT, James N. Wilson, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.